These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 26893557)

  • 1. Heterogeneous response of different tumor cell lines to methotrexate-coupled nanoparticles in presence of hyperthermia.
    Stapf M; Pömpner N; Teichgräber U; Hilger I
    Int J Nanomedicine; 2016; 11():485-500. PubMed ID: 26893557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methotrexate-conjugated and hyperbranched polyglycerol-grafted Fe₃O₄ magnetic nanoparticles for targeted anticancer effects.
    Li M; Neoh KG; Wang R; Zong BY; Tan JY; Kang ET
    Eur J Pharm Sci; 2013 Jan; 48(1-2):111-20. PubMed ID: 23108167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticancer medicines (Doxorubicin and methotrexate) conjugated with magnetic nanoparticles for targeting drug delivery through iron.
    Samra ZQ; Ahmad S; Javeid M; Dar N; Aslam MS; Gull I; Ahmad MM
    Prep Biochem Biotechnol; 2013; 43(8):781-97. PubMed ID: 23876138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate-coupled nanoparticles and magnetic nanochemothermia for the relapse-free treatment of T24 bladder tumors.
    Stapf M; Teichgräber U; Hilger I
    Int J Nanomedicine; 2017; 12():2793-2811. PubMed ID: 28435259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functionalized Magnetic Fe
    Nowak-Jary J; Płóciennik A; Machnicka B
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel platform designed by Au core/inorganic shell structure conjugated onto MTX/LDH for chemo-photothermal therapy.
    Tian DY; Wang WY; Li SP; Li XD; Sha ZL
    Int J Pharm; 2016 May; 505(1-2):96-106. PubMed ID: 26997424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MTX-Loaded Dual Thermoresponsive and pH-Responsive Magnetic Hydrogel Nanocomposite Particles for Combined Controlled Drug Delivery and Hyperthermia Therapy of Cancer.
    Najafipour A; Gharieh A; Fassihi A; Sadeghi-Aliabadi H; Mahdavian AR
    Mol Pharm; 2021 Jan; 18(1):275-284. PubMed ID: 33300343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The exposure of cancer cells to hyperthermia, iron oxide nanoparticles, and mitomycin C influences membrane multidrug resistance protein expression levels.
    Franke K; Kettering M; Lange K; Kaiser WA; Hilger I
    Int J Nanomedicine; 2013; 8():351-63. PubMed ID: 23378758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Octreotide-conjugated PAMAM for targeted delivery to somatostatin receptors over-expressed tumor cells.
    Peng J; Qi X; Chen Y; Ma N; Zhang Z; Xing J; Zhu X; Li Z; Wu Z
    J Drug Target; 2014 Jun; 22(5):428-38. PubMed ID: 24437350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate anticancer drug delivery to breast cancer cell lines by iron oxide magnetic based nanocarrier.
    Attari E; Nosrati H; Danafar H; Kheiri Manjili H
    J Biomed Mater Res A; 2019 Nov; 107(11):2492-2500. PubMed ID: 31298774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro anti-cancer efficacy of multi-functionalized magnetite nanoparticles combining alternating magnetic hyperthermia in glioblastoma cancer cells.
    Minaei SE; Khoei S; Khoee S; Vafashoar F; Mahabadi VP
    Mater Sci Eng C Mater Biol Appl; 2019 Aug; 101():575-587. PubMed ID: 31029351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyethylene glycol conjugates of methotrexate varying in their molecular weight from MW 750 to MW 40000: synthesis, characterization, and structure-activity relationships in vitro and in vivo.
    Riebeseel K; Biedermann E; Löser R; Breiter N; Hanselmann R; Mülhaupt R; Unger C; Kratz F
    Bioconjug Chem; 2002; 13(4):773-85. PubMed ID: 12121133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxyl-modified magnetite nanoparticles as novel carrier for delivery of methotrexate.
    Farjadian F; Ghasemi S; Mohammadi-Samani S
    Int J Pharm; 2016 May; 504(1-2):110-6. PubMed ID: 26994523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of nanostructured lipid carriers loaded with methotrexate: A tool for inflammatory and cancer therapy.
    Ferreira M; Chaves LL; Lima SA; Reis S
    Int J Pharm; 2015 Aug; 492(1-2):65-72. PubMed ID: 26169145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integration of phospholipid-hyaluronic acid-methotrexate nanocarrier assembly and amphiphilic drug-drug conjugate for synergistic targeted delivery and combinational tumor therapy.
    Li Y; Zhang H; Chen Y; Ma J; Lin J; Zhang Y; Fan Z; Su G; Xie L; Zhu X; Hou Z
    Biomater Sci; 2018 Jun; 6(7):1818-1833. PubMed ID: 29785434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifunctional nanoparticles as somatostatin receptor-targeting delivery system of polyaniline and methotrexate for combined chemo-photothermal therapy.
    Nguyen HT; Phung CD; Thapa RK; Pham TT; Tran TH; Jeong JH; Ku SK; Choi HG; Yong CS; Kim JO
    Acta Biomater; 2018 Mar; 68():154-167. PubMed ID: 29292170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Liposomal formulation of a methotrexate diglyceride conjugate: activity in methotrexate-resistant leukemia cultured cells].
    Vodovozova EL; Kuznetsova NR; Gaenko GP; Molotkovskiĭ IuG
    Bioorg Khim; 2007; 33(4):470-3. PubMed ID: 17886439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticancer effect of X-Ray triggered methotrexate conjugated albumin coated bismuth sulfide nanoparticles on SW480 colon cancer cell line.
    Faghfoori MH; Nosrati H; Rezaeejam H; Charmi J; Kaboli S; Johari B; Danafar H
    Int J Pharm; 2020 May; 582():119320. PubMed ID: 32278720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzymatic stimuli-responsive methotrexate-conjugated magnetic nanoparticles for target delivery to breast cancer cells and release study in lysosomal condition.
    Nosrati H; Mojtahedi A; Danafar H; Kheiri Manjili H
    J Biomed Mater Res A; 2018 Jun; 106(6):1646-1654. PubMed ID: 29441671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elegant pH-Responsive Nanovehicle for Drug Delivery Based on Triazine Dendrimer Modified Magnetic Nanoparticles.
    Landarani-Isfahani A; Moghadam M; Mohammadi S; Royvaran M; Moshtael-Arani N; Rezaei S; Tangestaninejad S; Mirkhani V; Mohammadpoor-Baltork I
    Langmuir; 2017 Aug; 33(34):8503-8515. PubMed ID: 28732161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.